These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 11371144)
1. Quality of life in ovarian cancer patients receiving chemotherapy. Lakusta CM; Atkinson MJ; Robinson JW; Nation J; Taenzer PA; Campo MG Gynecol Oncol; 2001 Jun; 81(3):490-5. PubMed ID: 11371144 [TBL] [Abstract][Full Text] [Related]
2. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel. Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A; J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330 [TBL] [Abstract][Full Text] [Related]
3. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Bezjak A; Tu D; Bacon M; Osoba D; Zee B; Stuart G; Roy JA; Piccart M; Eisenhauer E J Clin Oncol; 2004 Nov; 22(22):4595-603. PubMed ID: 15466785 [TBL] [Abstract][Full Text] [Related]
4. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108 [TBL] [Abstract][Full Text] [Related]
5. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment. Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950 [TBL] [Abstract][Full Text] [Related]
6. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
7. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial. Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013 [TBL] [Abstract][Full Text] [Related]
8. Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer. Gronlund B; Høgdall C; Hansen HH; Engelholm SA Gynecol Oncol; 2001 Oct; 83(1):128-34. PubMed ID: 11585424 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in the management of women with ovarian cancer. Eltabbakh GH Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan. Kato J; Nagahara A; Iijima K; Yoshimura M; Osada T; Yoshizawa T; Watanabe S J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S268-72. PubMed ID: 19120910 [TBL] [Abstract][Full Text] [Related]
12. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial. Butler L; Bacon M; Carey M; Zee B; Tu D; Bezjak A J Clin Oncol; 2004 Jun; 22(12):2461-8. PubMed ID: 15197209 [TBL] [Abstract][Full Text] [Related]
13. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
14. Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life. Brotto L; Brundage M; Hoskins P; Vergote I; Cervantes A; Casado HA; Poveda A; Eisenhauer E; Tu D; ; ; Support Care Cancer; 2016 Mar; 24(3):1241-9. PubMed ID: 26304156 [TBL] [Abstract][Full Text] [Related]
15. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Fader AN; von Gruenigen V; Gibbons H; Abushahin F; Starks D; Markman M; Belinson J; Rose P Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784 [TBL] [Abstract][Full Text] [Related]
16. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer. Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107 [TBL] [Abstract][Full Text] [Related]
17. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. McQuellon RP; Thaler HT; Cella D; Moore DH Gynecol Oncol; 2006 May; 101(2):296-304. PubMed ID: 16376417 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Hershman D; Jacobson JS; McBride R; Mitra N; Sundararajan V; Grann VR; Neugut AI Gynecol Oncol; 2004 Aug; 94(2):540-9. PubMed ID: 15297201 [TBL] [Abstract][Full Text] [Related]
19. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Hoppenau B; du Bois A; Gynecol Oncol; 2006 Feb; 100(2):300-7. PubMed ID: 16199079 [TBL] [Abstract][Full Text] [Related]
20. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO. Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ; J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]